| Title |
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
|
|---|---|
| Published in |
Diabetologia, January 2008
|
| DOI | 10.1007/s00125-007-0911-x |
| Pubmed ID | |
| Authors |
J. Rosenstock, M. Davies, P. D. Home, J. Larsen, C. Koenen, G. Schernthaner |
| Abstract |
This 52-week multinational, randomised, open-label, parallel-group, non-inferiority trial compared clinical outcomes following supplementation of oral glucose-lowering drugs with basal insulin analogues detemir and glargine in type 2 diabetic patients. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 172 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 3 | 2% |
| Brazil | 2 | 1% |
| France | 1 | <1% |
| Ecuador | 1 | <1% |
| Austria | 1 | <1% |
| South Africa | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 161 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 34 | 20% |
| Student > Master | 18 | 10% |
| Other | 17 | 10% |
| Student > Ph. D. Student | 14 | 8% |
| Student > Postgraduate | 13 | 8% |
| Other | 43 | 25% |
| Unknown | 33 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 83 | 48% |
| Agricultural and Biological Sciences | 8 | 5% |
| Biochemistry, Genetics and Molecular Biology | 7 | 4% |
| Nursing and Health Professions | 7 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 25 | 15% |
| Unknown | 36 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2015.
All research outputs
#4,475,888
of 22,919,505 outputs
Outputs from Diabetologia
#1,903
of 5,045 outputs
Outputs of similar age
#21,476
of 155,452 outputs
Outputs of similar age from Diabetologia
#6
of 22 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,045 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.7. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,452 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.